OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Mergers & Acquisitions
Mergers & Acquisitions Summary
Each week, Viridian publishes insights and analysis on completed M&A transactions in the prior week. Our analysis includes:
-
- M&A Market Commentary
- Public and Private Companies
- Buyers & Sellers
- YTD M&A Analysis
- M&A by Industry Sector
- Deal Structure and Valuation Analysis
- Pending Deal Risk Arb Analysis
- Valuation Gap Analysis
Quick Links
Transaction Activities
Week ended 05/19/2023
- Two M&A transactions closed this for $3.1M, compared to four transactions for $42.32M in the prior year.
YTD Activities
- Forty-nine transactions totaling $870.4M have closed YTD, compared to ninety-one transactions for $3,595.3M last year.
- The 2023 YTD average transaction size of $17.8M is the lowest in recent years.
Pending Risk Deal Arb Analysis
-
- The Cresco/Columbia deal spread narrowed by 4930 bp to 73.9% on 5/19/23. This spread indicates the market does not believe this deal will close as presently structured. Numerous reasons include the constrained capital markets making required divestitures in Ohio and Florida more challenging. The spread may also relate to the relative credit qualities of the two companies. Columbia Care “needs” the deal to close as its long-term liquidity profile is challenging as a standalone, whereas Cresco is somewhat better positioned. Columbia plans to achieve positive operating cash flow in 2023 through better working capital management and additional cost savings. Trading at around .9x 2023 revenues, Columbia seems like an intriguing spec with a lot of upside if the deal actually happens and only a modest downside if it doesn’t.
Valuation Gap Analysis
- The valuation gap widened to 3.73 on 5/19/23, the highest reading since 12/2/22. The valuation gap is the difference between the EV/NTM EBITDA multiple for the largest MSOs and the multiple for the less than $300M market cap group, which are their primary targets.
- This measure has been a significant driver of M&A activity since a larger gap creates an opportunity for more accretive transactions. The gap tends to increase in improving markets while declining in retreating markets to the greater trading liquidity of the larger companies. We believe the current gap is still understated by the massive illiquidity of cannabis stocks which may not be accurate indicators of the prices at which the entire companies would trade.
Please login to your account to view data charts.
